Evidence map›Paper›PMID 35076274›Full record

ArticlemSystems2022

Metabolic Disease, NAD Metabolism, Nicotinamide Riboside, and the Gut Microbiome: Connecting the Dots from the Gut to Physiology.

Anthony A Sauve

Open access · goldAbstract readComment
In one paragraph

Article in mSystems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Nicotinamide Riboside, a Promising Vitamin BMolecules (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anthony A SauveDepartment of Pharmacology, Weill Cornell Medical College, New York, New York, USA.
Cornell University · US

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Mechanisms of AHR Metabolic ToxicityR01ES027488 · NIEHS · WEILL MEDICAL COLL OF CORNELL UNIV · PI YANG, YUE · 2017 to 2021
$2.3M
NAD Metabolism in Aging and Disease: Dysfunction and InterventionR01AG066192 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI YANG, YUE · 2020 to 2024
$1.7M
NIA NIH HHS R01 AG066192NIDDK NIH HHS P30 DK020541NIEHS NIH HHS R01 ES027488
6 · The paper itself

Abstract

The effort to use nutrients as interventions to treat human disease has been important to medicine. A current example in this vein pertains to NAD

Indexed as

Gastrointestinal MicrobiomeMetabolic DiseasesMicrobiotaAnimalsDiet, High-FatHumansMiceNADNiacinamideNicotinamide MononucleotidePyridinium CompoundsWeight GainNADNiacinamidenicotinamide-beta-ribosideNicotinamide MononucleotidePyridinium Compoundsenergy metabolismmetabolic syndromemicrobiomeNAD+NAD+ metabolismnicotinamide riboside

Identifiers

PMID35076274
PMCPMC8788318
OpenAlexW4206935064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.